Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
In addition to their role in controlling water and salt homeostasis, recent work suggests that aldosterone and mineralocorticoid receptors (MR) may be involved in adipocyte biology. This is of particular relevance given the role of MR as a high‐affinity receptor for both mineralocorticoids and glucocorticoids. We have thus examined the effect of aldosterone and MR on white adipose cell differentiation. When cells are cultured in a steroid‐free medium, aldosterone promotes acquisition of the adipose phenotype of 3T3‐L1 and 3T3‐F442A cells in a time‐, dose‐, and MR‐dependent manner. In contrast, late and long‐term exposure to dexamethasone inhibits adipocyte terminal maturation. The aldosterone effect on adipose maturation was accompanied by induction of PPARγ mRNA expression, which was blocked by the MR antagonist spironolactone. Under permissive culture conditions, specific MR down‐regulation by siRNAs markedly inhibited 3T3‐L1 differentiation by interfering with the transcriptional control of adipogenesis, an effect not mimicked by specific inactivation of the glucocorticoid receptor. These results demonstrate that MR represents an important proadipogenic transcription factor that may mediate both aldosterone and glucocorticoid effects on adipose tissue development. MR thus may be of pathophysiological relevance to the development of obesity and the metabolic syndrome.–Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., Zennaro, M‐C. Pivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis. FASEB J. 21, 2185–2194 (2007)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aldosterone increases pre-adipocyte differentiation tissue in vivo (39)”
From Primary aldosteronism decreases insulin secretion and increases insulin clearance in humans (2020) · cites this paper as [39]
In the citing paper
“The adipocyte MRs may mediate a proadipogenic effect of both aldosterone () and GCs ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
In the citing paper
“MRs on adipocytes promoted the expression of inflammatory adipokines (-), giving rise to lower insulin receptor expression and impaired insulin-induced glucose uptake ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [175]
Citations
Cites
1 retracted
Kitagawa, H., Yanagisawa, J., Fuse, H., Ogawa, S., Yogiashi, Y., Okuno, A., Nagasawa, H., Nakajima, T., Matsumoto, T., & Kato, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.11.3698-3706.2002 · Cited by 101 · cited 1×
“This would not be surprising, since aldosterone and glucocorticoids have been shown to recruit different coregulators to MR-responsive promoters, thus differentially affecting gene transcription (24).”
BackgroundRetractedStimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
Understanding Adipocyte Differentiation
GREGOIRE, F. M., SMAS, C. M., & SUL, H. S. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.3.783 · Cited by 2,376 · cited 2×
“To better elucidate the mechanism of aldosterone action, we asked whether its proadipogenic effects were reproduced in 3T3-F442A cells, which are generally regarded as a model with a more advanced commitment in the adipose differentiation process (1); consistent with this, 3T3-F442A cell differentiation is independent…”
BackgroundArriza, J. L., Weinberger, C., Cerelli, G., Glaser, T. M., Handelin, B. L., Housman, D. E., & Evans, R. M. (1987) · Science · doi:10.1126/science.3037703 · Cited by 1,946 · cited 2×
“Exposure to aldosterone for 7 days was accompanied by a dose-dependent increase in cell triglyceride accumulation and G3PDH activity (Fig. 3C), with an EC50 value between 0.3 and 0.6 nM, consistent with the affinity of the MR for aldosterone ( 7 ).”
BackgroundInfluentialTranscriptional regulation of adipogenesis
Rosen, E. D., Walkey, C. J., Puigserver, P., & Spiegelman, B. M. (2000) · Genes & Development · doi:10.1101/gad.14.11.1293 · Cited by 1,898 · cited 1×
“It is generally recognized that C/EBP is involved early and transiently in the control of adipogenesis, while PPAR and C/EBP are involved more distally (26), and that expression of the relevant genes is regulated in a sequential and coordinated manner by environmental proadipogenic factors.”
BackgroundLacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 3×
“In vivo, convincing evidence exists for a major role of glucocorticoids on adipose differentiation, as elegantly demonstrated in transgenic animal models (2).”
BackgroundC/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494 · cited 1×
“sufficient to promote adipogenesis (27).”
Newell-Price, J., Bertagna, X., Grossman, A. B., & Nieman, L. K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68699-6 · Cited by 1,165
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Bookout, A. L., Jeong, Y., Downes, M., Yu, R. T., Evans, R. M., & Mangelsdorf, D. J. (2006) · Cell · doi:10.1016/j.cell.2006.06.049 · Cited by 1,015 · cited 1×
“Also supporting this hypothesis is recent evidence coming from anatomical profiling of nuclear receptor expression, showing that MR belongs to a cluster of receptors highly expressed in all tissues and is crucial for maintaining global basal metabolic functions ( 32 ).”
Background
Research works printed but not linked: 1
- 10.1210/mend.13.12.0384 · doi:10.1210/mend.13.12.0384 · Paper page
Cited by
Items 201–300 of 332
What Is the Role of the Adipocyte Mineralocorticoid Receptor in the Metabolic Syndrome?
Gómez-Sánchez, C. E. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.05148 · Cited by 15
Marzano, L. A., & Ronco, C. (2024) · Hypertension Research · doi:10.1038/s41440-023-01554-x · Cited by 18
“…strongest predictors of primary and secondary outcome, BMI was the only variable that negatively correlated and maintained statistical signi fi cance in the multivariable model for both CCS and CBS. Studies have shown that human adipocytes can stimulate aldosterone secretion and vice versa [32, 33].”
Strawberry fermentation with Cordyceps militaris has anti-adipogenesis activity
Guo, L., Li, K., Kang, J., Kang, N. J., Son, B. G., & Choi, Y. W. (2020) · Food Bioscience · doi:10.1016/j.fbio.2020.100576 · Cited by 15
Ishikawa, T., Morimoto, S., & Ichihara, A. (2021) · Hypertension Research · doi:10.1038/s41440-021-00836-6 · Cited by 14
“MR acts as a pro-adipogenic transcription factor in adipocytes [32].”
BackgroundPoleti, M., DeRijk, R. H., Rosa, A. F., Moncau, C. T., Oliveira, P. S., Coutinho, L. L., Eler, J. P., & Balieiro, J. C. D. C. (2014) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2014.12.004 · Cited by 14
Lee, S.-L., Lee, H.-K., Chin, T., Tu, S.-C., Kuo, M.-H., Kao, M., & Wu, Y. (2015) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x15500536 · Cited by 13
Ribeiro, R. S., Passos, C. S., Novaes, A. S., Maquigussa, E., da Glória, M. A., Visoná, I., Ykuta, O., Oyama, L. M., & Boim, M. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174721 · Cited by 15
Type 2 diabetes mellitus caused by Gitelman syndrome-related hypokalemia: A case report
He, G., Gang, X., Sun, Z., Wang, P., Wang, G., & Guo, W.-Y. (2020) · Medicine · doi:10.1097/md.0000000000021123 · Cited by 13
Ghoniem, A.-A., Açil, Y., Wiltfang, J., & Gierloff, M. (2015) · Anatomy & Cell Biology · doi:10.5115/acb.2015.48.2.85 · Cited by 13
“[23] described the only usage of corticoids like dexamethasone in longer-term differentiation could inhibit adipocytes terminal maturation, which was observed with NAM influence on hADSCs compared to hMSCs.”
ResultBigas, J., Sevilla, L. M., & Pérez, P. (2020) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.03.933 · Cited by 13
Huang, W., Chen, Y., Yang, S., Lai, C., Lai, T., Chen, H.-Y., Chen, L., Wang, Y.-J., Cheng, Y., Lang, C.-L., et al. (2023) · Hypertension Research · doi:10.1038/s41440-023-01203-3 · Cited by 11
“The presence of increased fat and excess aldosterone in patients with uPA has been implicated in the development of type 2 DM, hypertension, dyslipidemia, and cardiovascular disease [33, 34].”
BackgroundSilva, F. D. F., Komino, A. C. M., Andreotti, S., Reis, G. B., Caminhotto, R. D. O., Landgraf, R. G., de Souza, G. O., Sertié, R. A. L., Collins, S., Donato, J., et al. (2022) · Biomedicines · doi:10.3390/biomedicines10092328 · Cited by 15
“Compared to other synthetic GCs, dexamethasone has the advantage of low affinity for mineralocorticoid receptors (MR) [12], which could decrease the chances of side effects, since most are a result of the GC-MR binding [13,14].”
BackgroundAdipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51
Toneatto, J., Charó, N. L., Galigniana, N. M., & Piwien‐Pilipuk, G. (2015) · Adipocyte · doi:10.1080/21623945.2015.1049401 · Cited by 12
UCP1 transrepression in Brown Fat in vivo and mineralocorticoid receptor anti-thermogenic effects
Kuhn, E., Lamribet, K., Viengchareun, S., Menuet, D. L., Fève, B., & Lombès, M. (2018) · Annales d Endocrinologie · doi:10.1016/j.ando.2018.04.018 · Cited by 12
Self-citationNikolaidis, M. G., Kerksick, C. M., Lamprecht, M., & McAnulty, S. R. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/407978 · Cited by 16
Lastra‐González, G., Manrique‐Acevedo, C., & Sowers, J. R. (2008) · Current Diabetes Reports · doi:10.1007/s11892-008-0035-9 · Cited by 10
Aldosterone, mitochondria and regulation of cardiovascular metabolic disease
Tsai, C., Chen, Z., Lee, B., Liao, C., Chang, Y., Tsai, Y.-R., Chou, C., Wu, V., Hung, C., & Lin, Y. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0350 · Cited by 12
Pirih, F. Q. M., Abayahoudian, R., Elashoff, D. A., Parhami, F., Nervina, J. M., & Tetradis, S. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21931 · Cited by 11
“MR is expressed in osteoblasts and adipocytes [Beavan et al., 2001; Caprio et al., 2007].”
BackgroundThe effects of canrenone on inflammatory markers in patients with metabolic syndrome
Derosa, G., Romano, D., Bianchi, L., D’Angelo, A., & Maffioli, P. (2014) · Annals of Medicine · doi:10.3109/07853890.2014.969303 · Cited by 12
“Mineralocorticoid levels and activation of mineralocorticoid receptors are increased when metabolic syndrome is diagnosed (10), and this might be in part responsible for the increased cardiovascular risk in these patients (11,12).”
BackgroundEndocrinological aspects of sarcopenic obesity
Minnetti, M., Poggiogalle, E., Frigerio, F., Piciocchi, C., Pierantozzi, G., Vincenzo, O. D., Pinto, A., Gianfrilli, D., Isidori, A. M., Migliaccio, S., et al. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2626085 · Cited by 14
“In addition to their classical role in regulating water and salt homeostasis, aldosterone and mineralo-corticoid receptors have also been implicated in adipocyte biology, influencing adipose tissue expansion and metabolic activity [109].”
Azevedo, A., Santos, A. C., Ribeiro, L. V. P. T., & Azevedo, I. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9701-0_1 · Cited by 10
Adipogenesis and aldosterone: a study in lean tryptophan-depleted rats
Pokusa, M., Hlaváčová, N., Csanova, A., Franklin, M., Zórad, Š., & Ježová, D. (2016) · General Physiology and Biophysics · doi:10.4149/gpb_2016020 · Cited by 9
“adiponectin, leptin, resistin, PPARγ, IL-6, and promoted adipogenesis in 3T3L1 adipose cells (Caprio et al. 2007; Guo et al. 2008).”
BackgroundSharma, P., Banerjee, R., & Narayan, K. P. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.11.023 · Cited by 9
“The role of mineralocorticoids in controlling sodium and potassium transport in epithelial cells [7] and in non-epithelial tissues, such as cardiac myocytes, blood vessels, the hippocampus and adipose tissue [8-10] is well known.”
BackgroundFK506 binding protein 51: Its role in the adipose organ and beyond
Galigniana, N. M., Ruiz, M. C., & Piwien‐Pilipuk, G. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30351 · Cited by 12
Goncharov, N., Katsya, G. V., Gaivoronskaya, L. M., Zoloedov, V. I., Uskov, V. L., & Gooren, L. J. (2012) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2012-0023 · Cited by 10
“Mineralocorticoid receptor expression has been recorded with physiological concentrations of circulating aldosterone, and these receptors show a high affinity for both aldosterone and cortisol [42] .”
BackgroundReviving the use of aldosterone inhibitors in treating hypertension in obesity
Huby, A.-C., & de Chantemèle, E. J. B. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00133.2015 · Cited by 10
“Recent works highlighted the importance of the adipose tissue as new source of aldosterone (4) as well as a producer of yet unidentified factor(s) (7, 23) promoting aldosterone release.”
BackgroundThe mineralocorticoid receptor: a new player controlling energy homeostasis
Kuhn, E., & Lombès, M. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0033 · Cited by 10
“Conversely, aldosterone also exerts pro-adipogenic effects on white preadipocyte models (3T3-L1 and 3T3-F442A) in a dose-, time- and MR-dependent manner [61, 62] (Figure 2).”
BackgroundSelf-citationGreco, E. A., Feraco, A., Marzolla, V., Mirabelli, M., Cimino, L., Armani, A., Brunetti, A., & Caprio, M. (2021) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2021.07.010 · Cited by 8
Self-citationTherapeutic compounds for Cushing’s syndrome: a patent review (2012-2016)
Ma, L., Yin, L., & Hu, Q. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1217331 · Cited by 8
“Moreover, MR is found to be expressed in adipose cells and mediates pre-adipocyte differentiation and maturation [65].”
BackgroundCaprio, M., Zennaro, M., Fève, B., Mammi, C., Fabbri, A., & Rosano, G. M. C. (2008) · Climacteric · doi:10.1080/13697130802162608 · Cited by 9
Self-citationPuzantian, H. V., Townsend, R. R., & Bansal, S. (2024) · Journal of Clinical Hypertension · doi:10.1111/jch.14898 · Cited by 8
The invention of aldosterone, how the past resurfaces in pediatric endocrinology
Viengchareun, S., Pussard, E., Castanet, M., Sachs, L. M., Vu, T. A., Boileau, P., Lombès, M., & Martinerie, L. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111375 · Cited by 11
Self-citationMitsuno, R., Kaneko, K., Nakamura, T., Kojima, D., Mizutani, Y., Azegami, T., Yamaguchi, S., Yamada, Y., Jinzaki, M., Kinouchi, K., et al. (2023) · Journal of the Endocrine Society · doi:10.1210/jendso/bvad154 · Cited by 6
“Data obtained from studies conducted in cultured cells demonstrate that MR antagonists inhibits adipocyte differentiation [49, 50].”
BackgroundRastogi, A., & Weir, M. R. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108515 · Cited by 8
Bukovetzky, E., Schwimmer, H., Fares, F., & Haim, A. (2011) · Hormones and Behavior · doi:10.1016/j.yhbeh.2011.10.006 · Cited by 10
Manso, J., Pedron, M. C., Mondin, A., Censi, S., Pennelli, G., Galuppini, F., Barollo, S., Bertazza, L., Radu, C. M., Ghini, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020754 · Cited by 6
“…non-epithelial cells, such as brain neurons [3], cardiomyocytes [4], vascular smooth muscle cells [5], endothelial cells [6], mononuclear leukocytes [7], pre-adipocytes and adipocytes [8,9] and erythrocytes [10]. cells [5], endothelial cells [6], mononuclear leukocytes [8,9] and erythrocytes [10].”
BackgroundHsp90 as a therapeutic target in endocrinology: current evidence
Ratajczak, T., Ward, B. K., Walsh, J. P., & Cluning, C. (2015) · Research and Reports in Endocrine Disorders · doi:10.2147/rred.s68546 · Cited by 8
“Furthermore, in addition to GR, the mineralocorticoid receptor (MR) has been shown to play a pivotal role in adipocyte biology and helps mediate both aldosterone and glucocorticoid effects on adipose tissue development.(133) Peroxisome proliferator-activated receptor γ (PPARγ), also a member of the nuclear hormone rec…”
Lien, L. F., & Guyton, J. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00218.x · Cited by 5
The mineralocorticoid system, cardiometabolic health and its interplay with adipose tissue
Thuzar, M., Halim, M. A., & Stowasser, M. (2024) · Journal of Endocrinology · doi:10.1530/joe-24-0119 · Cited by 6
Breton, C. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0010 · Cited by 5
“In the WAT, it plays a critical role in the adipogenic transcriptional program, especially in the corticosteroid-induced adipocyte differentiation [90].”
BackgroundMineralocorticoid receptor activates postnatal adiposity in zebrafish lacking proopiomelanocortin
Rajeswari, J. J., Faught, E., Santos, H., & Vijayan, M. M. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31428 · Cited by 5
Medical Treatment of Primary Aldosteronism
Takeda, Y., Demura, M., & Yoneda, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_14 · Cited by 4
Steroid hormones and the stroma-vascular cells of the adipose tissue
Volat, F., & Bouloumié, A. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0023 · Cited by 4
Friedauer, K., Dänicke, S., Schulz, K., Sauerwein, H., & Häussler, S. (2014) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12268 · Cited by 3
Gao, S., Ito, H., Murakami, M., Yoshida, K., Tagawa, Y., Hagiwara, K., Takagi, A., Kojima, T., Suzuki, M., Banno, Y., et al. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22414 · Cited by 4
“These observations were compatible with those in previous report [Caprio et al., 2007].”
ResultReply to Armani et al. Can cortisol stimulate adipogenesis without the glucocorticoid receptor?
Lee, M.-J., & Fried, S. K. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.71 · Cited by 4
Menuet, D. L., Munier, M., Campostrini, G., & Lombès, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.036 · Cited by 3
“…MR has been recently identified as a potent pro-adipogenic transcription factor involved in the pathophysiology of obesity and metabolic syndrome, given that anti-mineralocorticoid compounds specifically prevent adipocyte differentiation and triglyceride accumulation (Caprio et al., 2007, 2011).”
Self-citationTreatment options for heart failure in individuals with overweight or obesity: a review
Nasoufidou, A., Stachteas, P., Karakasis, P., Kofos, C., Karagiannidis, E., Klisic, A. N., Popovic, D. S., Koufakis, T., Fragakis, N., & Patoulias, D. (2025) · Future Cardiology · doi:10.1080/14796678.2025.2479378 · Cited by 3
Aldosterone and its Cardiovascular Effects
Garg, R., & Adler, G. K. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-373870-7.00023-5 · Cited by 3
Various actions of aldosterone: The kidney and beyond…
Lombès, M. (2009) · Annales d Endocrinologie · doi:10.1016/j.ando.2009.02.011 · Cited by 4
Self-citationDietary and Hormonal Factors Involved in Healthy or Unhealthy Visceral Adipose Tissue Expansion
Zubiría, M. G., Alzamendi, A., Ongaro, L., Spinedi, E., & Giovambattista, A. (2017) · InTech eBooks · doi:10.5772/65927 · Cited by 2
“The actions of GC on AT cells can be exerted through their binding to MR and GR [79, 80], although the contribution of MR and GR in mediating GC effects on AT cells has not been fully understood.”
BackgroundMineralocorticoid Receptor and Aldosterone: From Hydro-saline Metabolism to Metabolic Diseases
Armani, A., & Caprio, M. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_14 · Cited by 4
Self-citationAdrenal–adipose tissue crosstalk in health and disease
Jiang, M., Stifel, U., Blüher, M., Lefèbvre, H., Bornstein, S. R., & Bechmann, N. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf252 · Cited by 4
Role of glucocorticoid receptor (GR) in white adipose tissue beiging
Martín, F. M., Alzamendi, A., Harnichar, A. E., Castrogiovanni, D. C., Zubiría, M. G., Spinedi, E., & Giovambattista, A. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121681 · Cited by 4
Insulin signaling in adipose tissue of patients with primary aldosteronism
Urbanet, R., Pilon, C., Giorgino, F., Vettor, R., & Fallo, F. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347035 · Cited by 3
De, R., Holmes, M. V., Moore, J. H., Ritchie, M. D., Verma, S. S., Asselbergs, F. W., Keating, B. J., & Gilbert‐Diamond, D. (2014) · IEEE International Conference on Systems Biology · doi:10.1109/isb.2014.6990744 · Cited by 2
Cibles rétiniennes d’action des médicaments
Béhar‐Cohen, F. (2011) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2011.01.003 · Cited by 2
Lumbera, W. M. L., Cruz, J. F. D., Yang, S. H., & Hwang, S. G. (2015) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.15.0677 · Cited by 2
“…hormonal induction for 48 hours with a combination of insulin, glucocorticoids and methylisobutylxanthine, which elevates intracellular cAMP levels in the presence of FBS. Dexamethasone, a synthetis glucocorticoid agonist, is used to stimulate the glucocorticoid receptor (Caprio et al., 2007).”
BackgroundAdipokines: another link between obesity and hypertension
Sabbatini, A. R., de Faria, A. P., Modolo, R., & Moreno, H. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.28 · Cited by 2
MicroRNAs in aldosterone production and action
MacKenzie, S. M., Birch, L. A., Lamprou, S., Rezvanisanijouybari, P., Fayad, M., Zennaro, M., & Davies, E. (2023) · Vitamins and hormones · doi:10.1016/bs.vh.2023.07.001 · Cited by 3
Self-citationTargeting mineralocorticoid receptors to treat metabolic diseases via the adipocyte
Armani, A., Gorini, S., Feraco, A., Mammi, C., Bellucci, E., & Caprio, M. (2026) · Endocrinology · doi:10.1210/endocr/bqag004 · Cited by 3
Self-citationMolecular Genomics of Mineralocorticoid Action
Fuller, P. J., & Young, M. J. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00043-7 · Cited by 1
Tatsuno (2008) · Molecular Medicine Reports · doi:10.3892/mmr_00000071 · Cited by 2
Genomic and Non-genomic Aldosterone Signaling
LaPointe, M. S. (2017) · Anatomy Physiology & Biochemistry International Journal · doi:10.19080/apbij.2017.01.555574
Phenomenon of hypocortisolism in individuals with obesity
Herhaus, B., Mekschrat, L., & Petrowski, K. (2025) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2025.100316 · Cited by 2
“There is evidence from animal and cell culture studies, that reduced MR plays a pivot role in the development of an abnormal functioning of the HPA-axis in obesity [46,47].”
Putnam, K. (2012) · UKnowledge (University of Kentucky) · Cited by 1
Gv, K., Goncharov, N. P., & Chagina, N. A. (2011) · Problems of Endocrinology · doi:10.14341/probl20115747-12 · Cited by 2
Corticosteroid Receptors, Their Chaperones and Cochaperones: How Do They Modulate Adipogenesis?
Toneatto, J., Charó, N. L., Naselli, A., Muñoz-Bernart, M., Lombardi, A., & Piwien‐Pilipuk, G. (2014) · Nuclear Receptor Research · doi:10.11131/2014/101092 · Cited by 1
“It has been reported that knock-down of GR by specific siRNA blocks the differentiation of 3T3-L1 preadipocytes [34] but other report provides some evidence that this is not the case [21].”
BackgroundInfluentialObesity, Cortisol Excess, and the Hypothalamic–Pituitary–Adrenal Axis
Hunter, L., & Syed, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-48559-3.00004-x · Cited by 1
Choi, Y. W., Guo, L., Kang, J., Park, Y., Je, B. I., Hwang, D., & Joo, W. (2020) · Asian Pacific Journal of Tropical Medicine · doi:10.4103/1995-7645.296724 · Cited by 1
Fernandes-Rosa, F. L. (2023) · Endocrinology · doi:10.1007/978-3-031-27119-9_12 · Cited by 1
PPARγ needs a helping hand to make fat
Cuaranta‐Monroy, I., & Nagy, L. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.151 · Cited by 2
Obesity-Related Aldosteronism is Associated with Adverse Cardiac Structure, Function, and AdiposityPreprint
Tsai, C., Chan, J. M., Milks, J., Ferrebus, A., Hanna, I., Mahrokhian, S., Newman, A. J., Stéfanie, P.-L. S., Marques, I. R., Foote, K., et al. (2025) · medRxiv · doi:10.1101/2025.11.12.25340075 · Cited by 1
Lundin, A. (2013) · Chalmers Publication Library (Chalmers University of Technology)
The regulation of preadipocyte differentiation by glucocorticoids
Tomlinson, J. J. (2007) · uO Research (University of Ottawa) · doi:10.20381/ruor-13103
Aldosterone and Cardiovascular Diseases
Tomaschitz, A., & Pilz, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_12
Poleti, M. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.74.2013.tde-22052013-152839
Alteraciones del proceso adipogénico in vitro en modelos experimentales de síndrome metabólico
Zubiría, M. G. (2014) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/35146
Neues zu Aldosteron und dem Mineralokortikoidrezeptor
Fiebeler, A. (2007) · Der Nephrologe · doi:10.1007/s11560-007-0119-6
Vers l’identification de nouveaux effets métaboliques du récepteur des minéralocorticoïdes
Fève, B. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70395-4
Self-citationKarashima, S. (2013) · Journal of Hypertension Open Access · doi:10.4172/2167-1095.1000130
“[23] reported that aldosterone promotes maturation of pre-adipocytes to adipocytes cells in a time-, dose-, and MR-dependent manner.”
BackgroundZiera, T. (2009) · DepositOnce · doi:10.14279/depositonce-2286
“the hippocampus, the heart, blood vessels, adipocytes and macrophages (15-18).”
The Effects Of Environmental Pollutants On Adipogenesis In The 3T3-L1 Model
Wang, J. (2015) · Digital Archive @ GSU · doi:10.57709/7899703
The Co-chaperones FKBP51 and PP5 Control Nuclear Receptor Phosphorylation and Adipogenesis
Stechschulte, L. A. (2013) · OhioLink ETD Center (Ohio Library and Information Network)
Corticosterone Modulates the Vasodilation by Perivascular Fat
Andersen, I. A. (2011) · Gothenburg University Publications Electronic Archive (Gothenburg University)
A Hsp90 és az adipogenezis kapcsolatának vizsgálata
Nguyễn, M. T. (2014) · Semmelweis University Repository (Semmelweis University) · doi:10.14753/se.2014.1971
“A dexametazon nemcsak a glükokortikoid receptorokat (GR) aktiválja, hanem a mineralokortikoid receptorokhoz (MR) is köt, hatására mind a C/EBPβ, mind a C/EBPδ pár óra alatt indukálódik (173).”
Sultana, N. (2015) · ThinkTech (Texas Tech University) · Cited by 1
da Silva, N. G. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.08.d.18766
Roberge, C., Carpentier, A. C., Langlois, M., Baillargeon, J., Ardilouze, J., & Gallo‐Payet, N. (2007)
Recettore mineralcorticoide e organo adiposo: implicazioni cliniche e terapeutiche
Caprio, M., Infante, M., Armani, A., Lenzi, A., & Fabbri, A. (2016) · L Endocrinologo · doi:10.1007/s40619-016-0179-9
“Il nostro gruppo di ricerca ha dimostrato che l’attivazione di MR incrementa l’espressione di marker adipocitari e promuove l’adipogenesi in colture di cellule adipose umane, così come il blocco farmacologico di MR mediante antagonisti recettoriali riduce la differenziazione adipocitaria [4, 5].”
BackgroundSelf-citationPrevention of Adverse Metabolic Consequences of Adipocyte Dysfunction Using MR Antagonists
Caprio, M., Marzolla, V., & Armani, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805421-5.00007-0
Self-citationTargeting obesity-related inflammation through nutritional and genetic approaches
LeMieux, M. J. (2015) · ThinkTech (Texas Tech University)
Estrés oxidativo en pacientes con diferente expresividad clínica del síndrome metabólico
Galván-Meléndez, M. F., Calderón-Salinas, J. V., Intriago-Ortega, M. D. P., Torres-Castorena, A., Escobedo, R. Z., Meléndez-Hurtado, C. D., & Escorza, M. A. Q. (2014) · Medicina Interna de México
Kuroda, K. (2019) · Juntendō Igaku/Juntendo igaku · doi:10.14789/jmj.2019.65.jmj18-r13
Mineralocorticoid Receptor in Novel Target Tissues: A Closer Look at the Adipocyte
Armani, A., Marzolla, V., Feraco, A., Gorini, S., Mammi, C., Infante, M., & Caprio, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.87231
Self-citationDevelopment of a biomarker panel for identifying stressed marine mammals
Busqueta, L. P., Deyarmin, J. S., McCormley, M. C., Champagne, C. D., Crocker, D., Houser, D. S., & Khudyakov, J. I. (2019) · Scholarly Commons (University of the Pacific)
Moseti, D. (2015) · Mspace (University of Manitoba)
Hormonal Mechanisms in Essential Hypertension
Dobrescu, M., Păun, D. L., Buculei, S., Grigorie, D., & Poiană, C. (2021) · Internal Medicine · doi:10.2478/inmed-2021-0167
Metadata
- Authors
- Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C.
- Affiliations
- University of Rome Tor Vergata (IT)
- Université Paris-Sud (FR)
- Inserm (FR)
- Corresponding author
- Zennaro, Maria-Christina
- ORCID
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2007-03-23
- Volume
- 21
- Issue
- 9
- Pages
- 2185-2194
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2020602591
- Semantic Scholar
- 734801b485ad9565f37131d53cbad945c833d55c
- Cited by
- 337
- References
- 37
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 7 · 2023: 13 · 2022: 15 · 2021: 8 · 2020: 18 · 2019: 13 · 2018: 19 · 2017: 20 · 2016: 26 · 2015: 30 · 2014: 36 · 2013: 23 · 2012: 18
- FWCI
- 7.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- onlinelibrary.wiley.com/termsAndConditions#vor (vor)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
- Funders
- Fondation pour la Recherche Médicale
- Institut National de la Santé et de la Recherche Médicale
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- mineralocorticoid receptor, aldosterone, adipogenesis, 3T3-L1 cells, dexamethasone, PPARγ, spironolactone, glucocorticoid receptor, obesity, metabolic syndrome, transcriptional regulation
- MeSH terms
- Aldosterone, Animals, Cell Differentiation, Cells, Cultured, Dexamethasone, Dose-Response Relationship, Drug, Insulin, Male, Obesity, Phenotype, Receptors, Glucocorticoid, RNA, Messenger, Spironolactone, Transcription, Genetic, Receptors, Mineralocorticoid, Metabolic Syndrome, RNA, Small Interfering, Swiss 3T3 Cells, PPAR gamma, Adipogenesis, Mice, Adipose Tissue, White, Adipocytes, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.